Eric Marcotulli, CEO, Elysium Health
Robert Johnston, CEO, Executive Council (Moderator)
Building a company from the ground up is hugely difficult (as every founder knows). And, truly disruptive models simply can't exist in the traditional healthcare constructs. In the "Wellness" category, there are dozens and dozens of companies pursuing prevention and proactivity. Elysium stands way out from the crowd. We'l dig into some of the research around aging, why Elysium (and some others) are different and take a closer look at healthspan as a meaningful measure. Also, many major pharma companies are shuttering their Alzheimer's and other drug development efforts in this genre. What does this mean for companies like Elysium?